Psyence Biomedical (PBM) Current Assets (2023 - 2026)

Psyence Biomedical's Current Assets history runs 4 years deep, the most recent figure standing at $9.1 million for Q1 2026.

• On a quarterly basis, Current Assets rose 38.87% year-over-year to $9.1 million in Q1 2026; TTM through Mar 2026 was $9.1 million, a 38.87% increase from a year earlier, with the FY2026 full-year figure at $9.1 million, up 38.87% from the prior year.
• Current Assets climbed to $9.1 million in Q1 2026 per PBM's latest filing, from $7.6 million in the prior quarter.
• Across five years, Current Assets topped out at $162.5 billion in Q3 2023 and bottomed at $1.1 million in Q1 2024.
• The 4-year median for Current Assets is $6.6 million (2025), against an average of $23.2 billion.
• Across the five-year window, Current Assets sank 100.0% in 2024 and soared 482.27% in 2025, its largest moves.
• Year by year, Current Assets stood at $162.5 billion in 2023, then sank by 100.0% to $2.2 million in 2024, then surged by 240.09% to $7.6 million in 2025, then gained by 19.41% to $9.1 million in 2026.
• Per Business Quant, the three latest PBM Current Assets figures stand at $9.1 million (Q1 2026), $7.6 million (Q3 2025), and $6.6 million (Q1 2025).